Reuters logo
BRIEF-Sun Pharmaceutical Industries says USFDA cites nine inspectional observations at Halol facility
December 8, 2016 / 9:18 AM / 10 months ago

BRIEF-Sun Pharmaceutical Industries says USFDA cites nine inspectional observations at Halol facility

Dec 8 (Reuters) - Sun Pharmaceutical Industries Ltd

* USFDA inspected the company’s Halol facility in Gujarat, India from November 17, 2016 through December 1, 2016

* At the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspectional observations

* Says intends to implement promptly any corrective actions that may be necessary as a result of the observations

* None of the observations were characterized by the USFDA as repeat observations Source text: bit.ly/2gdHpN5 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below